ARCHIVES

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 23 | June 15, 2007

Download PDF Visit The Full Archive

Related Articles

NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers

November 21, 1975

DeVita Seeks End to Funding For CROS, Reacts With Anger To Charge Of “Central Direction From Washington”

February 20, 1981

NCI-Approved Clinical Trials Listed For Month Of March

April 27, 2001

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011

NCI Raises R01 Payline To 16th Percentile FY09. Coalition Formed To Advocate For Medical Innovation

March 27, 2009

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014